Nanocarriers and their integrated microneedle systems-mediated drug delivery for the treatment of moderate-severe dermatological diseases: Recent progress, applications and future perspectives

IF 4.5 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Mridusmita Das, Rabinarayan Parhi
{"title":"Nanocarriers and their integrated microneedle systems-mediated drug delivery for the treatment of moderate-severe dermatological diseases: Recent progress, applications and future perspectives","authors":"Mridusmita Das,&nbsp;Rabinarayan Parhi","doi":"10.1016/j.jddst.2025.106748","DOIUrl":null,"url":null,"abstract":"<div><div>Dermatological diseases significantly affect patients' quality of life and psychological well-being due to their visible symptoms. Currently, treatment options for these conditions include systemic medications, topical treatments, phototherapy, radiotherapy, chemotherapy, surgical resection, and injections. However, each of these treatments has its limitations. In this context, transdermal drug delivery (TDD) is particularly appealing because it allows for the delivery of drugs to affected tissues, reducing systemic side effects. Unfortunately, the stratum corneum (SC), the outermost layer of the skin, severely hampers drug permeation. Nanocarriers loaded with drugs could offer a promising solution for penetrating this SC barrier due to their small size, ideally less than 100 nm. These nanocarriers can also enhance the solubility, stability and target delivery efficiency of the encapsulated drugs. However, the thickened and highly keratinized skin still acts as a barrier to the permeation of these nanocarriers. To overcome this issue, microneedles (MNs) with micron-sized needles can pierce the SC, enabling drug delivery into the viable epidermis and dermis layers of the skin. Therefore, nanocarrier-integrated MN systems can significantly improve drug targeting while minimizing systemic drug exposure and related side effects. This review discusses the anatomy of the skin, the pathways for drug permeation, and methods to enhance drug delivery through the skin, including both chemical and physical approaches. It specifically focuses on various nanocarriers used in TDD and their application in treating moderate to severe dermatological diseases such as psoriasis, atopic dermatitis, and melanoma. It also examines the current therapies for these conditions, advancements in nanocarrier technologies, their integration with MN systems, and their potential applications, along with the challenges and future directions in this field.</div></div>","PeriodicalId":15600,"journal":{"name":"Journal of Drug Delivery Science and Technology","volume":"106 ","pages":"Article 106748"},"PeriodicalIF":4.5000,"publicationDate":"2025-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drug Delivery Science and Technology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1773224725001510","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Dermatological diseases significantly affect patients' quality of life and psychological well-being due to their visible symptoms. Currently, treatment options for these conditions include systemic medications, topical treatments, phototherapy, radiotherapy, chemotherapy, surgical resection, and injections. However, each of these treatments has its limitations. In this context, transdermal drug delivery (TDD) is particularly appealing because it allows for the delivery of drugs to affected tissues, reducing systemic side effects. Unfortunately, the stratum corneum (SC), the outermost layer of the skin, severely hampers drug permeation. Nanocarriers loaded with drugs could offer a promising solution for penetrating this SC barrier due to their small size, ideally less than 100 nm. These nanocarriers can also enhance the solubility, stability and target delivery efficiency of the encapsulated drugs. However, the thickened and highly keratinized skin still acts as a barrier to the permeation of these nanocarriers. To overcome this issue, microneedles (MNs) with micron-sized needles can pierce the SC, enabling drug delivery into the viable epidermis and dermis layers of the skin. Therefore, nanocarrier-integrated MN systems can significantly improve drug targeting while minimizing systemic drug exposure and related side effects. This review discusses the anatomy of the skin, the pathways for drug permeation, and methods to enhance drug delivery through the skin, including both chemical and physical approaches. It specifically focuses on various nanocarriers used in TDD and their application in treating moderate to severe dermatological diseases such as psoriasis, atopic dermatitis, and melanoma. It also examines the current therapies for these conditions, advancements in nanocarrier technologies, their integration with MN systems, and their potential applications, along with the challenges and future directions in this field.

Abstract Image

求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.00
自引率
8.00%
发文量
879
审稿时长
94 days
期刊介绍: The Journal of Drug Delivery Science and Technology is an international journal devoted to drug delivery and pharmaceutical technology. The journal covers all innovative aspects of all pharmaceutical dosage forms and the most advanced research on controlled release, bioavailability and drug absorption, nanomedicines, gene delivery, tissue engineering, etc. Hot topics, related to manufacturing processes and quality control, are also welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信